Demo Sign up Log In

Regeneron Pharmaceuticals (REGN)

Operating Expenses

$2.29B

Quarterly · Period ending: Jun 30, 2026 · USD

REGN Operating Expenses

Latest reported$2.29Bperiod endingJun 30, 2026

Latest reported$2.29Bperiod endingJun 30, 2026

REGN Quarterly Operating Expenses ($0.00 → $2.29B)

Quarterly operating expenses

High-resolution chart · PNG

REGN operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Operating Expenses — Quarterly (USD)
Period ending	Operating Expenses (USD)
Jun 30, 2001	21,979,000
Mar 31, 2001	18,836,000
Dec 31, 2000	20,188,000
Sep 30, 2000	16,976,000
Jun 30, 2000	17,166,000
Mar 31, 2000	15,927,000
Dec 31, 1999	12,500,000
Sep 30, 1999	15,400,000
Jun 30, 1999	13,100,000
Mar 31, 1999	13,500,000
Dec 31, 1998	12,000,000
Sep 30, 1998	11,900,000
Jun 30, 1998	11,600,000
Mar 31, 1998	10,500,000
Dec 31, 1997	9,300,000
Sep 30, 1997	9,200,000
Jun 30, 1997	9,800,000
Mar 31, 1997	9,800,000
Dec 31, 1996	9,900,000
Sep 30, 1996	10,600,000
Jun 30, 1996	9,900,000
Mar 31, 1996	9,900,000
Dec 31, 1995	8,500,000
Sep 30, 1995	8,600,000
Jun 30, 1995	8,900,000
Mar 31, 1995	9,000,000
Dec 31, 1994	12,800,000
Sep 30, 1994	12,600,000
Jun 30, 1994	13,600,000
Mar 31, 1994	13,400,000
Dec 31, 1993	42,600,000
Sep 30, 1993	2,300,000
Jun 30, 1993	11,100,000
Mar 31, 1993	11,300,000
Dec 31, 1992	8,400,000
Sep 30, 1992	8,000,000
Jun 30, 1992	6,700,000
Mar 31, 1992	6,700,000
Dec 31, 1991	700,000
Sep 30, 1991	2,000,000
Jun 30, 1991	800,000
Mar 31, 1991	0
Dec 31, 1990	-8,300,000
Sep 30, 1990	0
Jun 30, 1990	0
Mar 31, 1990	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.